Cite
MLA Citation
Meletios A. Dimopoulos et al.. “Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.” American journal of hematology, vol. 98, no. 1, 2023, pp. E15–E19. http://access.bl.uk/ark:/81055/vdc_100172532078.0x00004e